SignalXSignalX

CME CME Group

FY2024 10-K
Filed: Feb 27, 2025
Financials
Security & Commodity Brokers, Dealers, Exchanges & ServicesSEC EDGAR
CME Group Overview

CME Group (CME) filed its fiscal year 2024 10-K annual report with the SEC on Feb 27, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2024 10-K

Business Overview

  • • Core business model: Global derivatives marketplace enabling trading across asset classes including futures and options
  • • No new products, services, or business segments introduced or emphasized in this filing year
+3 more insights

Management Discussion & Analysis

  • • Revenue $6.13B, up 10% YoY from $5.58B, driven by 9% volume growth in clearing and transaction fees
  • • Operating margin 64.1% vs 61.6%, net income $3.53B up 9% YoY
+3 more insights

Risk Factors

  • • Regulatory risk from failure to maintain BrokerTec Americas' FICC membership, requiring timely margin payments to avoid loss of customer trust and trading volumes
  • • Geopolitical exposure to regulatory changes in U.S., U.K., and E.U. jurisdictions impacting compliance costs and business structure globally
+3 more insights

Financial Summary
XBRL

Revenue

$6.1B

Net Income

$3.5B

Operating Margin

64.1%

Net Margin

57.5%

ROE

13.3%

Total Assets

$137.4B

EPS (Diluted)

$9.67

Operating Cash Flow

$3.7B

Source: XBRL data from CME Group FY2024 10-K filing on SEC EDGAR. All figures in USD.

Other CME Group Annual Reports

FY2025 10-K

Get deeper insights on CME Group

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available